Regent Pacific Group Limited (SEHK: 575)
Health Care · Pharmaceuticals · HK
HK$0.88
+3.55% today · +26.8% 1Y
Regent Pacific Group Limited (SEHK: 575) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $32.54M.
Over the last twelve months the share price has gained 26.8%, trading between 0.57 and 1.22.
Tweenvest scores Regent Pacific Group Limited across four factors: quality 14/100, value 54/100, growth 100/100. Its strongest factor is growth.
575 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $32.54M
- Revenue (TTM)
- $5.40M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.08
- 52-week high
- HK$1.22
- 52-week low
- HK$0.57
- Avg volume (3M)
- —
- Shares outstanding
- 291.82M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| biote Corp.NasdaqGM: BTMD | $32.98M | $1.12 | -2.61% |
| Tianda Pharmaceuticals LimitedSEHK: 455 | $32.88M | HK$0.12 | +1.69% |
| Syntara LimitedASX: SNT | $32.88M | AU$0.02 | +14.29% |
| Medical Developments International LimitedASX: MVP | $32.63M | AU$0.42 | -2.35% |
| PRISM BioLab Co.,LTDTSE: 206A | $32.45M | ¥139.00 | -4.79% |
| SoftOx Solutions ASOB: SOFTX | $32.42M | Nkr0.12 | -1.85% |
| MYUNGMOON Pharm co.,LtdKOSE: A017180 | $31.98M | ₩1,286.00 | +1.02% |
| Ambalal Sarabhai Enterprises LimitedBSE: 500009 | $31.90M | Rs40.29 | +6.25% |
Figures last refreshed Oct 11, 2026.